Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5716202 | Human Pathology | 2017 | 29 Pages |
Abstract
This study aims to examine the expression profiles of the miR-183 cluster (miR-96/182/183) in pheochromocytoma. Pheochromocytoma tissues were prospectively collected from 50 patients with pheochromocytoma. Expression of miR-183 cluster members and SDHB protein expression were analyzed in these tissues by quantitative real-time polymerase chain reaction and immunohistochemistry, respectively. The expression of miR-183 cluster members in pheochromocytomas was correlated with the clinical and pathological parameters of these patients. The expression levels of miR-183 cluster members were predominantly downregulated or deleted in pheochromocytoma. Low expression or deletion of miR-96 was predominantly noted in younger patients with pheochromocytoma (<50 years, PÂ =Â .01). Female patients in the study group showed marked deletion of miR-182 (PÂ =Â .05). Deletion of the cluster was also associated with SDHB protein expression in pheochromocytoma. Moreover, patients with low miR-183 cluster expression had a slightly better survival rate when compared with patients with high expression. To conclude, the findings indicate a role for miR-183 cluster members in the pathogenesis and clinical progression of pheochromocytoma.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Pathology and Medical Technology
Authors
Suja MD, Chung Y. MBBS, MS, FRCS, Victor MBBS, FRACS, Minella MBBS, Robert A. PhD, Vinod PhD, Alfred King-Yin MBBS, MD, PhD, FRCPA,